Form 4: Danimer Scientific Director John P. Amboian Reports Share Distribution and RSU Vesting

Sentiment:

SEC Form 4 Filing


Director John P. Amboian reports a pro rata share distribution from Live Oak Sponsor Partners, LLC and vesting of restricted stock units.

Summary

  • John P. Amboian, a director of Danimer Scientific, Inc., reported changes in beneficial ownership of the company's Class A Common Stock on June 1, 2024.
  • These changes include a pro rata in-kind distribution of shares from Live Oak Sponsor Partners, LLC to its members, including the John P. Amboian 2008 Living Trust and Kings Trail Trust Dtd 09/19/2018, for which Amboian or his spouse serve as trustee.
  • Amboian also reported the vesting of 26,578 Restricted Stock Units (RSUs) on June 1, 2024, which converted into shares of Class A Common Stock.
  • Amboian disclaims beneficial ownership of shares held by the Living Trust and Kings Trail Trust except to the extent of any pecuniary interest.
  • A Limited Power of Attorney was executed on June 4, 2023, appointing Stephen A. Martin, Spencer E. Walker, Michael S. Nancarrow, and Blake R. Chamblee as attorneys-in-fact for Section 16 reporting and Form 144 obligations.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing, indicating routine transactions. The vesting of RSUs is generally a positive sign, suggesting continued service by the director.

Positives

  • The vesting of RSUs indicates continued service and alignment with the company's long-term incentives.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Form 4 filings are a regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading.
  • Similar filings are common among directors and officers of companies like Amyris, Inc. and Origin Materials, Inc., which also operate in the bioplastics and sustainable materials sector.
  • The reporting of RSU vesting is a standard component of executive compensation disclosures, comparable to practices at other publicly listed firms.

Stakeholder Impact

  • Shareholders are informed about changes in insider ownership, promoting transparency.
  • The vesting of RSUs can be seen as a positive sign, aligning director interests with shareholder value.

Key Dates

DateDescription
2023-06-04Date of execution for the Limited Power of Attorney.
2024-06-01Date of the pro rata share distribution and vesting of restricted stock units.
2024-06-04Date of filing the Form 4.

Keywords

Danimer Scientific, DNMR, Form 4, beneficial ownership, director, John P. Amboian, restricted stock units, RSU, Live Oak Sponsor Partners, share distribution, Section 16, Form 144, power of attorney

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.